RyCarma Therapeutics (Formerly ARMGO)

Edgewise Therapeutics

This biopharmaceutical company develops small molecule therapies for patients with serious cardiovascular diseases and musculoskeletal conditions like Duchenne and Becker muscular dystrophy.

Edgewise

This biopharmaceutical company develops oral small molecule therapies to treat patients with rare skeletal and cardiac muscle diseases.

Augustine Therapeutics

This company develops small molecule inhibitors to treat patients with neuromuscular, neurodegenerative and cardio-metabolic diseases.

Arvada Therapeutics

This biotechnology company develops large-molecule therapeutics to treat patients suffering from abnormal heart rhythms and arrhythmogenic right ventricular cardiomyopathy.

Acesion Pharma ApS

This biotech company develops small-molecule drugs to treat atrial fibrillation by inhibiting ion channels for patients with cardiac arrhythmia.

Serca Pharmaceuticals

This company develops cardioprotective drugs to treat patients suffering from myocardial infarction and heart failure by modulating the SERCA2 calcium pump.

Brano Therapeutics

This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.

Ribometrix

The company develops small molecule therapeutics targeting RNA structures to treat human diseases for pharmaceutical partners and patients with cancer or neurodegenerative conditions.